EXHIBIT 32.2
                            CERTIFICATION PURSUANT TO
                                 18 U.S.C. 1350,
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002


In  connection  with the  Quarterly  Report  of AJ & J PHARMA  CORPORATION  (the
"Company") on Form 10-QSB for the period ended  September 30, 2005 as filed with
the Securities  and Exchange  Commission on the date hereof (the  "Report"),  I,
Kevin Ericksteen,  Chief Financial Officer of the Company,  certify, pursuant to
18 U.S.C.  1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of
2002, that:

The Report fully complies with the requirements of Section 13(a) or 15(d) of the
Securities Exchange Act of 1934; and

The  information  contained  in the  Report  fairly  presents,  in all  material
respects, the financial condition and results of operations of the Company.


                                                   /s/ Kevin Ericksteen
                                                   --------------------------
Date: November 4, 2005                                 Kevin Ericksteen
                                                       Chief Financial Officer